n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
PIOMBINO DESE, Italy, March 11, 2024–(BUSINESS WIRE)–Stevanato Group S. p. A. (NYSE: STVN), a leading global provider of diagnostic, delivery and drug containment responses to the pharmaceutical, biotechnology and life sciences industries, announced its participation in the KeyBanc Capital Markets Virtual Investor Forum on Life Sciences and Medical Technologies, which will take place from Tuesday, March 19, 2024 to Wednesday, March 20, 2024.
The Company will toast on Tuesday, March 19, 2024 at 1:30 p. m. (ET). A live webcast will be held on the Company’s online page at www. stevanatogroup. com in the “Investors” section. A replay of the webcast will be held for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of diagnostic, delivery and drug containment responses to the pharmaceutical, biotechnology and life sciences industries. The group offers an integrated, end-to-end portfolio of products, processes and facilities that meet the needs of the world. Stevanato Group’s core functions in clinical studies and development, its commitment to technical innovation and its engineering excellence are at the heart of its ability to deliver value. -Aggregated responses to visitors.
For more information, visit www. stevanatogroup. com.
See the businesswire. com edition: https://www. businesswire. com/news/home/20240311378559/en/
Contactos
Stevanato Groupmedia@stevanatogroup. com Media
Investor Relations Lisa Mileslisa. miles@stevanatogroup. com